Answers are grounded in this paper and cite their sources.
Acetazolamide is the mainstay of medical therapy for idiopathic intracranial hypertension (IIH). Other approved indications for acetazolamide include glaucoma, congestive heart failure, and epilepsy [1]. The main mechanism of action of acetazolamide is reversible inhibition of the enzyme carbonic anhydrase resulting in reduced hydrogen ion (H+) secretion at the proximal renal tubules and an increased renal excretion of sodium, potassium, bicarbonate, and a relative increase in serum chloride concentration [1,2].
No takes yet. Share an insight, caveat, or question.
Samarth Shukla (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: